Pediatrix Medical (MD) Cash from Investing Activities (2009 - 2026)

Pediatrix Medical (MD) has reported Cash from Investing Activities for 18 consecutive years, with $6.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 184.13% year-over-year to $6.0 million in Q2 2026; TTM through Jun 2026 was -$9.6 million, a 53.87% increase from a year earlier, with the FY2025 full-year figure at -$18.3 million, up 48.33% from the prior year.
• Cash from Investing Activities was $6.0 million for Q2 2026 at Pediatrix Medical, up from -$12.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $6.6 million in Q3 2025 and troughed at -$26.3 million in Q1 2022.
• A 5-year average of -$9.2 million and a median of -$10.8 million in 2022 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 252.24% in 2025, down 430.55% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$11.2 million in 2022, then dropped by 10.52% to -$12.4 million in 2023, then jumped by 84.4% to -$1.9 million in 2024, then plunged by 430.55% to -$10.3 million in 2025, then jumped by 158.54% to $6.0 million in 2026.
• The last three Cash from Investing Activities figures came in at $6.0 million (Q2 2026), -$12.0 million (Q1 2026), and -$10.3 million (Q4 2025), per Business Quant data.